Total Payments
$30,118
2022 Payments
$1,790
Companies
10
Transactions
36
Payment Breakdown by Category
Consulting$13,440 (44.6%)
Other$10,517 (34.9%)
Travel$4,892 (16.2%)
Food & Beverage$1,269 (4.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $13,440 | 5 | 44.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,941 | 3 | 19.7% |
| Travel and Lodging | $4,892 | 12 | 16.2% |
| Honoraria | $4,576 | 2 | 15.2% |
| Food and Beverage | $1,269 | 14 | 4.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | $6,786 | 6 | $0 (2018) |
| Shire North American Group Inc | $5,741 | 12 | $0 (2017) |
| EMD Serono, Inc. | $5,345 | 4 | $0 (2018) |
| Omeros Corporation | $3,639 | 6 | $0 (2019) |
| UCB, Inc. | $2,923 | 2 | $0 (2019) |
| Echosens North America, Inc. | $2,076 | 1 | $0 (2017) |
| Kite Pharma, Inc. | $1,790 | 1 | $0 (2022) |
| GENZYME CORPORATION | $1,041 | 1 | $0 (2021) |
| Pharmacyclics LLC, An AbbVie Company | $750.00 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $26.59 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $1,790 | 1 | Kite Pharma, Inc. ($1,790) |
| 2021 | $1,791 | 2 | GENZYME CORPORATION ($1,041) |
| 2019 | $6,562 | 8 | Omeros Corporation ($3,639) |
| 2018 | $12,157 | 12 | BioMarin Pharmaceutical Inc. ($6,786) |
| 2017 | $7,818 | 13 | Shire North American Group Inc ($5,741) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/23/2022 | Kite Pharma, Inc. | Yescarta (Drug) | Consulting Fee | Cash or cash equivalent | $1,790.00 | General |
| Category: CELLT | ||||||
| 12/01/2021 | GENZYME CORPORATION | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,041.00 | General |
| 10/07/2021 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2019 | Omeros Corporation | narsoplimab (Drug) | Honoraria | Cash or cash equivalent | $2,500.00 | General |
| Category: Immunology | ||||||
| 09/11/2019 | Omeros Corporation | narsoplimab (Drug) | Travel and Lodging | In-kind items and services | $1,028.08 | General |
| Category: Immunology | ||||||
| 09/11/2019 | Omeros Corporation | narsoplimab (Drug) | Food and Beverage | In-kind items and services | $49.00 | General |
| Category: Immunology | ||||||
| 09/11/2019 | Omeros Corporation | narsoplimab (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Immunology | ||||||
| 09/11/2019 | Omeros Corporation | narsoplimab (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Immunology | ||||||
| 09/11/2019 | Omeros Corporation | narsoplimab (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Immunology | ||||||
| 05/15/2019 | UCB, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 04/08/2019 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $122.96 | General |
| 10/03/2018 | EMD Serono, Inc. | Mavenclad (Biological) | Consulting Fee | Cash or cash equivalent | $4,800.00 | General |
| Category: Neurology | ||||||
| 10/03/2018 | EMD Serono, Inc. | Mavenclad (Biological) | Travel and Lodging | In-kind items and services | $53.54 | General |
| Category: Neurology | ||||||
| 10/01/2018 | BioMarin Pharmaceutical Inc. | BMN 250 (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: MPB IIIB | ||||||
| 09/21/2018 | EMD Serono, Inc. | Mavenclad (Biological) | Travel and Lodging | In-kind items and services | $357.01 | General |
| Category: Neurology | ||||||
| 09/21/2018 | EMD Serono, Inc. | Mavenclad (Biological) | Travel and Lodging | In-kind items and services | $134.74 | General |
| Category: Neurology | ||||||
| 08/27/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/16/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/24/2018 | BioMarin Pharmaceutical Inc. | BMN 250 (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: MPB IIIB | ||||||
| 02/24/2018 | BioMarin Pharmaceutical Inc. | BMN 250 (Biological) | Food and Beverage | In-kind items and services | $812.74 | General |
| Category: MPB IIIB | ||||||
| 02/24/2018 | BioMarin Pharmaceutical Inc. | BMN 250 (Biological) | Travel and Lodging | In-kind items and services | $774.60 | General |
| Category: MPB IIIB | ||||||
| 02/24/2018 | BioMarin Pharmaceutical Inc. | BMN 250 (Biological) | Travel and Lodging | In-kind items and services | $241.92 | General |
| Category: MPB IIIB | ||||||
| 02/24/2018 | BioMarin Pharmaceutical Inc. | BMN 250 (Biological) | Travel and Lodging | In-kind items and services | $56.34 | General |
| Category: MPB IIIB | ||||||
| 10/24/2017 | Echosens North America, Inc. | Fibroscan (Device) | Honoraria | Cash or cash equivalent | $2,076.15 | General |
| Category: Elastography | ||||||
| 09/19/2017 | Shire North American Group Inc | ADVATE (Biological) | Consulting Fee | Cash or cash equivalent | $3,300.00 | General |
| Category: HEMATOLOGY | ||||||
About Dr. David Epstein, D.O
Dr. David Epstein, D.O is a General Practice healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2010. The National Provider Identifier (NPI) number assigned to this provider is 1639481187.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Epstein, D.O has received a total of $30,118 in payments from pharmaceutical and medical device companies, with $1,790 received in 2022. These payments were reported across 36 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($13,440).
Ad
Practice Information
- Specialty General Practice
- Location Atlanta, GA
- Active Since 07/12/2010
- Last Updated 07/12/2010
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639481187
Products in Payments
- BMN 250 (Biological) $6,786
- ADVATE (Biological) $5,741
- Mavenclad (Biological) $5,345
- narsoplimab (Drug) $3,639
- Fibroscan (Device) $2,076
- Yescarta (Drug) $1,790
- IMBRUVICA (Drug) $750.00
- ENTRESTO (Drug) $26.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Atlanta
Dr. Jonathan Nguyen, D.o, D.O
General Practice — Payments: $368,289
General Practice $368,289
Dr. Stanton Mckenna, Md, MD
General Practice — Payments: $75,744
General Practice $75,744
Ms. Edith Biggers, Md, MD
General Practice — Payments: $20,945
General Practice $20,945
Dr. Timothy Resuta, Dmd, DMD
General Practice — Payments: $15,927
General Practice $15,927
Dr. Charles Schramm, M.d, M.D
General Practice — Payments: $15,838
General Practice $15,838
Dr. James Wheeler, M.d, M.D
General Practice — Payments: $15,712
General Practice $15,712